期刊文献+
共找到608篇文章
< 1 2 31 >
每页显示 20 50 100
Seroprevalence of hepatitis B surface antigen in pregnant women attending antenatal clinic in Honiara Solomon Islands,2015 被引量:2
1
作者 Aneley Getahun Margaret Baekalia +5 位作者 Nixon Panda Alice Lee Elliot Puiahi Sabiha Khan Donald Tahani Doris Manongi 《World Journal of Hepatology》 CAS 2016年第34期1521-1528,共8页
AIMTo determine the seroprevalence of hepatitis B surface antigen (HBsAg) among pregnant women attending antenatal clinic in Honiara, Solomon Islands. METHODSThis descriptive cross-sectional study was carried out in s... AIMTo determine the seroprevalence of hepatitis B surface antigen (HBsAg) among pregnant women attending antenatal clinic in Honiara, Solomon Islands. METHODSThis descriptive cross-sectional study was carried out in seven area health centers in Honiara. From March to June 2015, identification of eligible pregnant women in each site was conducted using systematic random sampling technique. A total of 243 pregnant women who gave written informed consent were enrolled. Standardized tool was used to record demographics, obstetric history and serology results. HBsAg and hepatitis B e antigen (HBeAg) were tested using point-of-care rapid diagnostic test. All HBsAg positive samples were verified using enzyme-linked immunosorbent assay. RESULTSThe mean age of participants was 26 &plusmn; 6 years. The overall hepatitis HBsAg prevalence was 13.8% with higher rate (22%) reported in women between 30-34 years of age. Majority of HBsAg positive participants were Melanesians (29 out for 33). None of the pregnant women in the 15-19 years and &ge; 40 years tested positive for HBsAg. There was no statistically significant difference in HBsAg prevalence by age, ethnicity, education and residential location. The overall HBeAg seroprevalence was 36.7%. Women between 20-24 years of age had the highest rate of 54.5%. Low level of knowledge about hepatitis B vaccination was reputed. Overall, 54.6% of participants were not aware of their hepatitis B vaccination status and only 65.2% of mothers reported their child had been vaccinated. CONCLUSIONHepatitis B is a disease of public health importance in Solomon Islands and emphasize the need for integrated preventative interventions for its control. 展开更多
关键词 hepatitis b Chronic hepatitis hepatitis b surface antigen hepatitis b e antigen SEROPREVALENCE pregnant women Solomon Islands
下载PDF
Hepatitis B Infection and Immunity among Pregnant Women Attending Antenatal Clinics in Health Centers of Mbarara Municipality, Southwestern Uganda
2
作者 Immaculate Kabajulizi Joel Bazira +2 位作者 Collins Atuheire Charles Kato Taseera Kabanda 《Advances in Infectious Diseases》 2019年第2期65-79,共15页
Introduction: Viral hepatitis B (HBV) in pregnancy is a risk for childhood transmission where the majority become chronically infected. In Uganda, HBV is not tested for during antenatal, therefore the number of infect... Introduction: Viral hepatitis B (HBV) in pregnancy is a risk for childhood transmission where the majority become chronically infected. In Uganda, HBV is not tested for during antenatal, therefore the number of infected, infectious, immune and none-immune pregnant women is unknown curtailing efforts to prevent mother to child transmission. Methods: We conducted a descriptive cross-sectional study involving 254 pregnant women from four health centers in Mbarara Municipality. HBV status was assessed using an immunochromatographic (COMBO) kit, the type of infection;based on demonstration of anti hepB core IgM (acute infection) and total core IgG antibodies (chronic infection) and infectiousness;based on the presence of HBeAg and/or a quantitative HBV viral load ≥ 20,000 IU/mL. Immunity was determined using the COMBO kit and HBsAb quantification ELISA. One was deemed immune to HBV if HBsAb titers were ≥10 mIU/mL. Results: The prevalence of HBV infection was 1.2%;33% and 67% with acute and chronic HBV respectively. 33% were infectious based on a high viral load, none had detectable HBeAg. 14% were immune;amongst whom 72% had natural exposure and 18% after vaccination. There was insufficient immunity in 11% with a majority (75%) having acquired immunity following vaccination. Conclusion: The prevalence of HBV is low and most of those are chronically infected. HBeAg and Hepatitis B viral load should be performed when evaluating infectiousness. Further, there is a high transmission of HBV among adults and a low uptake of the HBV vaccine in Mbarara Municipality. 展开更多
关键词 hepatitis b Virus Prevalence Acute and Chronic VIRAL Load IMMUNITY pregnant women
下载PDF
Risk Factors, Clinical Features, Baseline Alanine Aminotransferase and CD4+ Count of Children with HIV Co-Infection with Hepatitis B and C at a Tertiary Hospital in Southwest Nigeria 被引量:1
3
作者 M. O. Durowaye S. K. Ernest I. A. Ojuawo 《International Journal of Clinical Medicine》 2016年第4期280-291,共12页
Background: Human immunodeficiency virus and hepatitis B and C viruses are endemic in sub- Saharan African countries including Nigeria. Researchers have studied the burden of co-infection of HIV with hepatitis B and h... Background: Human immunodeficiency virus and hepatitis B and C viruses are endemic in sub- Saharan African countries including Nigeria. Researchers have studied the burden of co-infection of HIV with hepatitis B and hepatitis C but the risk factors and clinical presentation have not been much addressed especially in children. Methodology: This was a prospective cross sectional study that determined the prevalence, risk factors, clinical features, baseline CD4<sup>+</sup> count, CD4<sup>+</sup> percentage, and alanine aminotransferase (ALT) of newly diagnosed, HAART na?ve HIV co-infection among children who were managed at a Tertiary Hospital in Ilorin, Nigeria. Result: Of the 60 HIV- infected children recruited, 11.7% had HIV co-infection with HBV or HCV. Children with co-infec- tions (mean age 8.43 ± 2.37 years) were significantly older than their HIV mono-infected counterparts (mean age 5.25 ± 3.96 years) (p = 0.011). There was no significant difference between HIV monoinfection and HIV co-infection with respect to gender (p = 0.758), ethnicity (p = 0.707), religion of parents (p = 0.436), family type (p = 0.184), social class (p = 0.535), previous transfusion (p = 0.053), scarification (p = 0.612), female genital mutilation (p = 0.778), and sharing of clippers (p = 0.806). The mean BMI, immunological staging (p = 0.535), baseline ALT (p = 0.940), and mean baseline CD4<sup>+</sup> count (p = 0.928) were comparable. However, the body mass index of HIV co-infec- ted children decreased with age up till age 10 years. Conclusion: There were no risk factors, nor clinical features predictive of co-infection identified in this study. Co-infection did not negatively impact baseline, CD4<sup>+</sup> count and ALT. 展开更多
关键词 CO-INFECTION hepatitis b hepatitis C Human Immunodeficiency Virus Acquired Immunodeficiency Syndrome HIV HbV HCV Alanine Aminotransferase ALT highly Active Antiretroviral Therapy HAART Monoinfection CD4+ risk Factors for Co-Infection Transmission hepatitis b Surface Antigen HbVsAg
下载PDF
阻断HBV母婴传播:热点与难点
4
作者 尹雪如 洪睿轩 +1 位作者 刘志华 侯金林 《临床肝胆病杂志》 CAS 北大核心 2024年第11期2141-2144,共4页
慢性HBV感染是我国最重要的公共卫生问题之一,HBV感染人群超过7000万,防控工作面临着严峻挑战。当前政府及社会各界正在加速推进“2030年实现消除病毒性肝炎对公众健康的威胁”的宏伟目标。母婴传播是HBV最主要的传播途径,因此,做好HBV... 慢性HBV感染是我国最重要的公共卫生问题之一,HBV感染人群超过7000万,防控工作面临着严峻挑战。当前政府及社会各界正在加速推进“2030年实现消除病毒性肝炎对公众健康的威胁”的宏伟目标。母婴传播是HBV最主要的传播途径,因此,做好HBV母婴阻断是消除病毒性肝炎的关键一环。目前在该领域存在一些热点与难点问题亟需解决,包括妊娠期采用富马酸丙酚替诺福韦长期治疗的安全性、妊娠早期抗病毒治疗的安全性、无免疫球蛋白策略的有效性和HBV经生殖细胞传播的风险等,解决这些问题对进一步推进HBV母婴阻断工作,加快我国实现2030年目标的进程具有重要作用。 展开更多
关键词 乙型肝炎病毒 传染性疾病传播 垂直 孕妇
下载PDF
Epidemiology of hepatitis B virus infection in Albania 被引量:10
5
作者 Bashkim Resuli Skerdi Prifti +3 位作者 Bledar Kraja Tatjana Nurka Mimoza Basho Edita Sadiku 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第7期849-852,共4页
AIM: To assess the prevalence and socio-demographic distribution of hepatitis B virus (HBV) infection in Albania. METHODS: Blood samples from 410 unselected schoolboys, 666 students, 500 military personnel, 1286 c... AIM: To assess the prevalence and socio-demographic distribution of hepatitis B virus (HBV) infection in Albania. METHODS: Blood samples from 410 unselected schoolboys, 666 students, 500 military personnel, 1286 casual blood donors, 378 voluntary blood donors and 640 pregnant women (total 3880 non-vaccinated residents of rural and metropolitan areas from all over Albania; 2354 (60.7%) male and 1526 (39.3%) female; mean age of 26.3 years) were tested during 2004-2006 for hepatitis B surface antigen (HBsAg) and antibodies to hepatitis B virus (anti-HBs) by ELISA. RESULTS: The HBsAg and anti-HBs prevalence were 9.5% and 28.7%, respectively. The highest HI3sAg prevalence was evident in the younger age group, such as in schoolchildren (11.8%) and the military (10.6%). Consequently, the anti-HBs prevalence increased with age, from 21.2% in schoolchildren (mean age: 15.7 years), to 36.3% in pregnant women (mean age: 26.3 years) and 29.7% in voluntary blood donors (mean age: 40.1 years). There were no significant differences between males and females. CONCLUSION: Despite the estimated two-fold reduction of HBsAg prevalence in the general population from about 18%-19% to 9.5%, Albania remains a highly endemic country (i.e. over 8% of HBsAg prevalence rate). 展开更多
关键词 Albania hepatitis b virus blood donor MILITARY pregnant women SCHOOLCHILDREN STUDENT
下载PDF
HBV高载量孕妇孕期抗病毒治疗结合标准阻断措施阻断母婴传播效果 被引量:1
6
作者 杨敏 李红梅 +3 位作者 张雷 何流 邓强 江海燕 《中国计划生育学杂志》 2024年第5期1153-1157,共5页
目的:探究乙型肝炎病毒(HBV)高载量孕妇孕期HBV-DNA水平和乙型肝炎病毒e抗原(HBeAg)阳性情况,分析孕期抗病毒治疗结合标准阻断措施对HBV高载量孕妇母婴传播阻断效果。方法:回顾性收集2021年1月-2023年1月本院住院分娩的120例HBV高载量... 目的:探究乙型肝炎病毒(HBV)高载量孕妇孕期HBV-DNA水平和乙型肝炎病毒e抗原(HBeAg)阳性情况,分析孕期抗病毒治疗结合标准阻断措施对HBV高载量孕妇母婴传播阻断效果。方法:回顾性收集2021年1月-2023年1月本院住院分娩的120例HBV高载量孕妇临床资料,分析孕妇妊娠期、分娩前HBV-DNA水平和HBeAg阳性率,多因素logistic回归分析HBeAg状态影响因素,分析孕期抗病毒治疗对新生儿乙肝母婴传播阻断效果及母婴安全性。结果:120例HBV高载量孕妇中,孕期接受抗病毒治疗93例(治疗组),抗病毒药物分别为替诺福韦占56.6%、拉米夫定占20.8%;未接受治疗27例(未治疗组)。妊娠期,抗病毒治疗组和未治疗组HBV-DNA载量、HBeAg阳性率无差异(P>0.05);分娩前,抗病毒治疗组HBV-DNA载量≥10^(6)IU/ml占比(7.5%)低于未治疗组(92.6%)(P<0.05),而两组HBeAg阳性率(90.3%、92.6%)无差异(P>0.05)。多因素logistic分析,年龄低、HBVDNA载量高影响HBeAg状态的独立危险因素(P<0.05)。新生儿乙肝母婴传播阻断率抗病毒治疗组(100.0%)高于未治疗组(2例,92.6%)(P<0.05)。两组新生儿体质量、早产、剖宫产、妊娠合并症、产时并发症比较无差异(P>0.05)。结论:HBV高载量孕妇HBV-DNA水平较高,HBeAg阳性率与孕妇年龄低、HBV-DNA载量高有关;孕期抗病毒治疗可降低孕妇分娩前HBV-DNA水平,结合标准阻断措施后可提高HBV母婴传播阻断率,且安全性较好。 展开更多
关键词 孕妇 乙型肝炎病毒 病毒DNA载量 乙肝E抗原 抗病毒治疗 母婴传播阻断
下载PDF
妊娠晚期感染B族链球菌孕妇早产的危险因素及其pbp2x基因突变分析 被引量:1
7
作者 文强 王秀 +2 位作者 丁小莉 胡芷晴 徐志红 《现代医药卫生》 2024年第13期2206-2210,共5页
目的 分析某院感染B族链球菌(GBS)孕妇发生早产的危险因素及观察早产孕妇感染GBS的pbp2x基因突变情况。方法 选取2022年1月至2023年5月在该院分娩且感染GBS的孕妇199例,根据早产与否分为观察组(41例)和对照组(158例)。采用二分类logisti... 目的 分析某院感染B族链球菌(GBS)孕妇发生早产的危险因素及观察早产孕妇感染GBS的pbp2x基因突变情况。方法 选取2022年1月至2023年5月在该院分娩且感染GBS的孕妇199例,根据早产与否分为观察组(41例)和对照组(158例)。采用二分类logistic回归模型和受试者操作特征(ROC)曲线分析感染GBS的孕妇发生早产的危险因素;对早产孕妇的GBS样本进行pbp2x基因一代测序分析。结果 199例感染GBS孕妇中发生早产41例,发生率为20.6%。Logistic回归分析显示,年龄[比值比(OR)=1.151,P=0.004)]和口服葡萄糖耐量试验(OGTT)异常项数(OR=2.995,P<0.001)是感染GBS孕妇发生早产的独立危险因素。两危险因素联合预测早产的曲线下面积(AUC)为0.783,最佳敏感度为75.6%,特异度为69.0%,较单项危险因素预测价值高。pbp2x基因测序发现3个错义突变(1129G>A、1148T>G、1528A>G),未发现影响GBS对青霉素敏感性的基因突变。结论 年龄和OGTT异常项数是感染GBS孕妇发生早产的危险因素,两者联合预测的效能优于单项,早产孕妇感染的GBS中尚未发现影响青霉素敏感性的pbp2x基因突变。 展开更多
关键词 b族链球菌 孕妇 早产 危险因素 pbp2x基因
下载PDF
41例慢性HBV感染危重孕产妇的临床特征分析 被引量:1
8
作者 鞠宇豪 李文 +3 位作者 王雨 肖玲燕 郑以山 韩国荣 《临床肝胆病杂志》 CAS 北大核心 2024年第2期258-263,共6页
目的分析慢性HBV感染的危重孕产妇临床特点及其转归,为救治危重孕产妇和防治肝病重症化提供临床经验。方法选取2013年3月—2023年3月南京市第二医院重症医学科收治的慢性HBV感染的孕产妇41例,通过医院电子病历系统收集孕产妇的临床资料... 目的分析慢性HBV感染的危重孕产妇临床特点及其转归,为救治危重孕产妇和防治肝病重症化提供临床经验。方法选取2013年3月—2023年3月南京市第二医院重症医学科收治的慢性HBV感染的孕产妇41例,通过医院电子病历系统收集孕产妇的临床资料,总结乙型肝炎孕产妇转入ICU的主要原因、死亡原因、治疗情况等。正态分布的计量资料两组间比较采用成组t检验;非正态分布的计量资料两组间比较采用Mann-Whitney U检验。计数资料两组间比较采用χ^(2)检验。结果13例(31.71%)患者未正规产检,8例(19.51%)高病毒载量患者(HBV DNA≥2×10^(5)IU/mL)未接受抗病毒治疗。主要的分娩方式为剖宫产32例(78.05%),婴儿早产23例(56.10%),患者死亡5例(12.20%)。转入ICU的前3位病因分别为肝衰竭、产后大出血和妊娠高血压疾病。肝衰竭主要在孕晚期发病,最多见并发症为肝性脑病(28.57%),最多见合并症为妊娠期肝内胆汁淤积症(21.43%);6例(42.86%)产检规律;13例(92.86%)入院前未接受抗病毒治疗。产后大出血患者平均ICU住院时间为(3.31±1.65)d,其中合并重症肝病者分娩前出现凝血功能异常,治疗48 h仍难以纠正。结论慢性HBV感染的孕产妇病情复杂,病死率较高。评估肝脏状态、定期产检和及时行抗病毒治疗对减少慢性HBV孕产妇重症发病、降低病死率尤为重要。 展开更多
关键词 乙型肝炎病毒 孕妇 症状和体征
下载PDF
HBsAg阳性孕妇及新生儿血清IL-6、IL.17、IL-23水平与HBV宫内感染关系
9
作者 邱洲群 闵敏 +2 位作者 李蓉 黄久浪 何雪 《中国计划生育学杂志》 2024年第7期1668-1672,共5页
目的:探讨乙肝表面抗原(HBsAg)阳性孕妇及新生儿血清白细胞介素(IL)-6、IL-17、IL-23水平与乙肝病毒(HBV)宫内感染关系。方法:回顾性收集2021年1月-2023年12月本院就诊的HBsAg阳性孕妇140例的临床资料为HBsAg阳性组,按照新生儿脐带血检... 目的:探讨乙肝表面抗原(HBsAg)阳性孕妇及新生儿血清白细胞介素(IL)-6、IL-17、IL-23水平与乙肝病毒(HBV)宫内感染关系。方法:回顾性收集2021年1月-2023年12月本院就诊的HBsAg阳性孕妇140例的临床资料为HBsAg阳性组,按照新生儿脐带血检测结果分为宫内感染组(n=28)与未感染组(n=112),同期HBsAg阴性孕妇140例为HBsAg阴性组。比较孕妇孕28周时外周血及新生儿脐血血清IL-6、IL-17、IL-23水平。受试者工作特征(ROC)曲线分析HBsAg阳性孕妇血清IL-6、IL-17、IL-23水平判断HBV宫内感染临床价值。结果:宫内感染组孕妇血清IL-6(104.33±24.92 ng/L)、IL-17(282.65±76.71 ng/L)、IL-23(269.52±64.28 ng/L)水平均高于未感染组(70.34±18.61、123.41±43.02、113.75±41.68)ng/L与HBsAg阴性组(68.13±17.18、119.53±37.13、110.32±44.43)ng/L(均P<0.05),未感染组与HBsAg阴性组无差异(P>0.05),各组新生儿脐带血清IL-6、IL-17、IL-23水平无差异(P>0.05)。ROC曲线分析,HBsAg阳性孕妇血清IL-6、IL-17、IL-23评估HBV宫内感染的曲线下面积分别为0.791、0.725、0.745,敏感度及特异度在61.6%~78.6%,有一定临床参考价值。结论:宫内感染孕妇孕28周时血清IL-6、IL-17、IL-23水平升高,3项指标对判断HBsAg阳性孕妇发生HBV宫内感染风险有一定临床指导价值。 展开更多
关键词 乙肝表面抗原阳性 乙肝病毒 孕妇 新生儿 宫内感染 白细胞介素 评估
下载PDF
Sero-Prevalence of HBV, HCV and HEV among the Egyptian Pregnant Females
10
作者 Suzan Samir Elsharkawy Wael Samir Elgazayerli 《Open Journal of Obstetrics and Gynecology》 2019年第10期1429-1438,共10页
Background: Viral hepatitis in pregnant women can be caused by multiple types of hepatitis viruses and can cause a wide range of symptoms and complications, ranging from asymptomatic infection to maternal and fetal de... Background: Viral hepatitis in pregnant women can be caused by multiple types of hepatitis viruses and can cause a wide range of symptoms and complications, ranging from asymptomatic infection to maternal and fetal deaths. Objective: The aim of this study was to evaluate the sero-prevalence and the associated factors of viral hepatitis B (HBV), viral hepatitis C (HCV) and viral hepatitis E (HEV) among the Egyptian pregnant females. Methods: This cross-sectional study was conducted in the period from January to July 2017 in two selected antenatal clinics;El-shat by maternity university hospital at Alexandria city and El-Behera health insurance antenatal clinic at Damanhur city on 261 apparently healthy gravid women. Eligible women were evaluated by a questionnaire about socio-demographic data and viral serological tests were done at El-shat by maternity University Hospital Laboratory. Results: The overall HBs-Ag sero-prevalence in the pregnant women included in this study was 7 cases (2.7%) and HCV-RNA PCR was 4 cases (1.5%). Of the total study participants, none of them (0%) were anti-HEV IgM positive and 48 cases (18.4%) were anti-HEV IgG positive. According to our results, neither age of the woman, place of residence, past family history of hepatitis virus infection nor having a pet animal had any strong association to be considered as an associated factor for acquiring HEV infection. Conclusion: Although it seems that there are many improvements in the prevalence of different hepatitis viruses in the country, hepatitis viral infections are still high enough to continue their preventive programs and health education, to protect the mothers and their fetuses from the hazardous effects of these serious infections. 展开更多
关键词 VIRAL hepatitis hepatitis b VIRUS hepatitis C VIRUS hepatitis E VIRUS pregnant women
下载PDF
CHB肝硬化患者aMAP评分与HEV之间的相关性分析
11
作者 胡羽 张倩倩 +2 位作者 肖强 曹传坤 孔德润 《安徽理工大学学报(自然科学版)》 CAS 2024年第2期87-93,共7页
目的探讨慢性乙型肝炎肝硬化患者aMAP评分与高危食管静脉曲张(HEV)发生风险之间的关联性。方法选取2017年1月1日至2023年1月1日于安徽医科大学第一附属医院确诊为慢性乙型肝炎肝硬化的患者为研究对象。收集所有研究对象的一般资料,同时... 目的探讨慢性乙型肝炎肝硬化患者aMAP评分与高危食管静脉曲张(HEV)发生风险之间的关联性。方法选取2017年1月1日至2023年1月1日于安徽医科大学第一附属医院确诊为慢性乙型肝炎肝硬化的患者为研究对象。收集所有研究对象的一般资料,同时收集入院24小时内的实验室检查指标并计算aMAP评分。所有研究对象均完成胃镜检查以评估食管静脉曲张(EV)程度。采用多元Logistic回归评估aMAP评分与HEV风险之间的相关性,采用趋势性检验(P for trend)评估两者之间的相关性是否存在剂量反应关系,最后采用平滑曲线拟合和阈值效应分析明确两者之间是否存在非线性关系。结果最终共纳入患者207例,其中HEV患者104例。与非HEV患者相比,HEV患者aMAP评分更高(P=0.002)。在多个模型中,aMAP评分与HEV之间存在明显的正向相关关系,全调整模型的结果为(OR=1.16,95%CI∶1.03-1.30)。随着aMAP评分的增加,HEV的发生风险也随之增加,趋势性检验具有显著的统计学差异(P for trend<0.01),平滑曲线拟合分析和阈值效应分析提示两者之间为直线效应关系。受试者工作特征曲线(ROC)下面积(AUC)为0.73(0.64-0.78),aMAP评分对HEV诊断的最佳截断值为63.57。结论在慢性乙型肝炎肝硬化患者中,aMAP评分与HEV发病风险之间存在直线性的正性相关关系,并且随着aMAP评分的升高这种正性相关关系更加明显。aMAP评分对HEV具有较好的诊断价值,最佳截断值为63.57。 展开更多
关键词 慢性乙型病毒性肝炎 肝硬化 高危食管静脉曲张 aMAP评分 横断面研究
下载PDF
慢性HBV感染孕妇产后肝炎活动与治疗管理
12
作者 陈婧 丁洋 《临床肝胆病杂志》 CAS 北大核心 2024年第11期2164-2167,共4页
慢性HBV感染孕妇产后由于免疫功能和激素水平变化,可出现肝炎活动。加强慢性HBV感染孕妇产后肝功能、HBV血清标志物和HBV DNA的监测与优化抗病毒治疗策略,对于确保产妇延缓疾病进展和母婴的安全性至关重要。本文将针对慢性HBV感染孕妇... 慢性HBV感染孕妇产后由于免疫功能和激素水平变化,可出现肝炎活动。加强慢性HBV感染孕妇产后肝功能、HBV血清标志物和HBV DNA的监测与优化抗病毒治疗策略,对于确保产妇延缓疾病进展和母婴的安全性至关重要。本文将针对慢性HBV感染孕妇产后肝炎活动的临床特点、发病机制和预测因素及治疗策略进行阐述,帮助临床医生更好地监测慢性HBV感染孕妇产后肝炎活动及治疗管理。 展开更多
关键词 乙型肝炎病毒 孕妇 治疗学
下载PDF
Prevention of Mother-to-Child Transmission of Hepatitis B in the Urban District Health Baskuy Burkina Faso
13
作者 Alice Nanelin Guingané Nicolas Meda +5 位作者 Roger Sombié Christiane Béré/Somé Lydie Sia Rose Ido/Da Issa Guiraud Alain Bougouma 《Open Journal of Gastroenterology》 2016年第6期175-187,共13页
Few studies have been conducted on the epidemiology in pregnancy in sub-Saharan Africa. This study aimed to improve the care of pregnant women infected with hepatitis B virus (VHB) and their newborns in the urban dist... Few studies have been conducted on the epidemiology in pregnancy in sub-Saharan Africa. This study aimed to improve the care of pregnant women infected with hepatitis B virus (VHB) and their newborns in the urban district health. Method: This study was conducted from 01/09/2014 to 01/09/2015. Study involved three types of data collection: a collection of data from health facilities involved in the project;repeated cross-sectional survey among health personnel;a pros- pective study of pregnant women identified positive for HBsAg and followed at the University Hospital Yalgado Ouédraogo (CHU-YO). Knowledge assessment was made among health staff and pregnant women using a knowledge score. Construction of the score came after a factorial analysis of multiple correspondences on population health workers surveyed in the first round (N = 119) on one hand and all pregnant women (N = 266) on the other hand. This had identified among the 79/19 questions, those that discriminated best knowledge of paramedics and pregnant women. For pregnant women, this score was then dichotomized from the center and logistic regression was performed to determine the sociodemographic, medical and obstetric characteristics that influenced it (p value < 005). Results: Health staff had been surveyed twice (N = 119/100). In general, the level of knowledge was good on targeted knowledge, both before and after training. No health worker routinely offered screening for hepatitis B among pregnant women attending antenatal clinics. Altogether 266 pregnant women HBsAg-positive were referred and followed CHU-YO. Half of the patients had a score lower than 2/17. Univariate analysis showed that variables such as education level influenced significantly the level of knowledge. Women with higher levels of education had a higher level of knowledge about the disease, compared to those of primary level [OR = 1.63;[1.34 to 1.99], p value < 0,001]. Newborns during the study period numbered 128 and the vaccine was made in the first 24 hours of life for 83.6% of them. Conclusion: routine screening for infection with VHB during pregnancy and improved knowledge of mothers is strongly reco- mmended in Burkina Faso. 展开更多
关键词 hepatitis b PARAMEDICS KNOWLEDGE PRACTICES pregnant women IMMUNIZATION NEWbORN
下载PDF
Effects of High Risk Pregnancy Factors on Pelvic Floor Muscle Weakness and Changes of PG, ACTH and CRP
14
作者 Yu Han Haiyan Lin +6 位作者 Jiu Du Lianfang Chen Xianmei Wei Peijia Wei Biyun Zhou Xiangli Feng Siran Chen 《Open Journal of Obstetrics and Gynecology》 2023年第9期1569-1579,共11页
Objective: To investigate the effects of different delivery modes on perinatal pelvic floor muscle strength, PG, ACTH and CRP of high-risk pregnant women. Methods: 380 high-risk pregnant women who gave birth in our ho... Objective: To investigate the effects of different delivery modes on perinatal pelvic floor muscle strength, PG, ACTH and CRP of high-risk pregnant women. Methods: 380 high-risk pregnant women who gave birth in our hospital from March 2021 to February 2022 were selected as subjects, including 100 vaginal natural delivery, 156 forceps assisted delivery and 124 cesarean section. Pelvic floor pressure, PG, ACTH, CRP, IL-6, TNF-α and IL-4, IL-10 levels were evaluated and compared. The perinatal occurrence of pelvic floor functional disease (PFD) in high-risk pregnant women in each group was analyzed and evaluated. Results: There were statistical differences in the amount of postpartum blood loss (P 0.0001, F = 99.01), postpartum blood loss 24 h (P = 0.0004, F = 19.54) and hospital stay (P 0.0001, F = 70.81) among the three groups of high-risk women in natural vaginal delivery, forceps delivery and cesarean section. In addition, there were 72, 134 and 70 cases of abnormal pelvic floor fatigue in natural vaginal delivery, forceps assisted delivery and cesarean section (P 0.0001, χ<sup>2</sup> = 30.16). There were 36, 79 and 21 cases of muscle injury, respectively (P 0.0001, χ<sup>2</sup> = 34.16). There were 49, 98 and 43 cases of dysmuscular contraction, respectively (P 0.0001, χ<sup>2</sup> = 21.94). There were 65, 120 and 41 cases with vaginal dynamic pressure 80 cm H<sub>2</sub>O (P 0.0001, χ<sup>2</sup> = 56.86), respectively. The. 展开更多
关键词 high-risk pregnant women Pelvic Floor Muscle Strength Stress Response Inflammatory Response
下载PDF
妊娠期抗病毒治疗阻断HBV母婴传播的新进展
15
作者 韩国荣 江红秀 《临床肝胆病杂志》 CAS 北大核心 2024年第11期2158-2163,共6页
HBV母婴传播是导致我国慢性乙型肝炎疾病高负担的主要原因之一,阻断这一传播途径对消除乙型肝炎具有至关重要的战略意义。新生儿出生立即实施联合免疫接种是阻断HBV母婴传播的基本策略,但在高病毒血症母亲中仍有9%的母婴传播率。近年来... HBV母婴传播是导致我国慢性乙型肝炎疾病高负担的主要原因之一,阻断这一传播途径对消除乙型肝炎具有至关重要的战略意义。新生儿出生立即实施联合免疫接种是阻断HBV母婴传播的基本策略,但在高病毒血症母亲中仍有9%的母婴传播率。近年来,孕期抗病毒干预阻断母婴传播的研究取得了突破,对消除乙型肝炎母婴传播具有划时代意义。孕期抗病毒干预与婴儿出生后联合免疫接种的综合预防,已成为消除乙型肝炎母婴传播的关键策略。本文总结了妊娠期抗病毒干预阻断母婴传播的发展历程和最新进展,并归纳相关干预策略和适应证等,旨在为临床和公共卫生医生提供参考。 展开更多
关键词 乙型肝炎病毒 传染性疾病传播 垂直 孕妇
下载PDF
富马酸丙酚替诺福韦对HBV感染免疫耐受期孕妇母婴阻断效果及安全性评价
16
作者 张丽媛 符芳翔 +2 位作者 郑小静 李娟 杜永国 《生命科学仪器》 2024年第3期69-70,74,共3页
目的研究富马酸丙酚替诺福韦对乙型肝炎病毒(HBV)感染免疫耐受期孕妇的母婴阻断效果及安全性。方法选取2021年1月至2023年1月在海南医学院第二附属医院诊治的28例HBV感染免疫耐受期孕妇,根据抗病毒方案分为富马酸替诺福韦二吡呋酯(TDF)... 目的研究富马酸丙酚替诺福韦对乙型肝炎病毒(HBV)感染免疫耐受期孕妇的母婴阻断效果及安全性。方法选取2021年1月至2023年1月在海南医学院第二附属医院诊治的28例HBV感染免疫耐受期孕妇,根据抗病毒方案分为富马酸替诺福韦二吡呋酯(TDF)组和富马酸丙酚替诺福韦(TAF)组。对比两组HBV DNA载量、肾小球滤过率(eGFR)、尿β2微球蛋白及不良反应发生率。结果两组治疗后HBV DNA较治疗前下降,P<0.05;两组治疗后eGFR与治疗前对比,P>0.05;治疗后TDF组尿β2微球蛋白较治疗前明显升高,且高于TAF组,P<0.05。两组不良反应发生率对比,P>0.05。两组新生儿HBV DNA、HBsAg和HBeAg检测结果均为阴性。结论对HBV感染免疫耐受期孕妇采用富马酸丙酚替诺福韦治疗的效果显著,可有效降低其HBV DNA载量,获得良好的母婴阻断效果,且对肾脏的安全性良好。 展开更多
关键词 乙型肝炎病毒感染 耐受期孕妇 富马酸丙酚替诺福韦 母婴阻断
下载PDF
孕妇孕晚期生殖道B群链球菌感染的现状及危险因素研究
17
作者 龚梅 崔莹 黄海汛 《标记免疫分析与临床》 CAS 2024年第4期653-657,共5页
目的分析孕妇孕晚期生殖道B群链球菌(GBS)感染的现状及相关危险因素。方法选取2021年3月至2023年1月257例于本院完成产检孕晚期孕妇,均接受生殖道GBS检查,依据是否发生生殖道GBS感染,分为GBS感染组与无GBS感染组,收集并比较两组临床资料... 目的分析孕妇孕晚期生殖道B群链球菌(GBS)感染的现状及相关危险因素。方法选取2021年3月至2023年1月257例于本院完成产检孕晚期孕妇,均接受生殖道GBS检查,依据是否发生生殖道GBS感染,分为GBS感染组与无GBS感染组,收集并比较两组临床资料,使用Logistic回归分析模型分析生殖道GBS感染相关危险因素。结果257例孕晚期孕妇中,48例(18.68%)检查为GBS感染,分离菌株中包含β溶血菌株45株(93.75%),非β溶血菌株3株(6.25%);GBS感染组年龄≥35岁、妊娠期糖尿病(GDM)、妊娠期高血压(HDCP)、妊娠期肥胖、孕期阴道炎孕妇占比显著高于无GBS感染组(P<0.05);Logistic回归分析显示,≥35岁、GDM、妊娠期肥胖、孕期阴道炎为孕晚期生殖道GBS感染危险因素(P<0.05)。结论孕妇孕晚期存在较高生殖道GBS感染风险,主要危险因素包括≥35岁、GDM、妊娠期肥胖、孕期阴道炎等,临床应重点关注该类群体,采取针对性干预措施,以降低GBS感染风险。 展开更多
关键词 孕妇 孕晚期 b群链球菌 危险因素
下载PDF
HBV感染孕产妇宫内感染发生情况及与病毒载量关系
18
作者 马倩 李小青 顾丽丽 《中国计划生育学杂志》 2024年第5期1144-1147,共4页
目的:探究乙型肝炎病毒(HBV)感染不同类型、HBV-DNA病毒载量孕产妇宫内感染发生情况,分析不同HBV-DNA病毒载量与细胞因子水平相关性。方法:选取本院2020年1月-2023年10月产前检查并足月分娩的乙型肝炎病毒表面抗原(HBsAg)阳性孕妇100例... 目的:探究乙型肝炎病毒(HBV)感染不同类型、HBV-DNA病毒载量孕产妇宫内感染发生情况,分析不同HBV-DNA病毒载量与细胞因子水平相关性。方法:选取本院2020年1月-2023年10月产前检查并足月分娩的乙型肝炎病毒表面抗原(HBsAg)阳性孕妇100例及其新生儿,统计新生儿HBV宫内感染情况,检测产妇HBV-DNA病毒载量水平,对比不同乙肝感染类型、HBV-DNA病毒载量孕产妇宫内感染发生率,不同HBV-DNA病毒载量孕产妇白介素-6(IL-6)、干扰素γ(IFN-γ)水平差异,Spearman相关系数分析HBV-DNA病毒载量与IL-6、IFN-γ的相关性。结果:100例孕产妇中HBsAg+HBeAg+HBcAb感染36例(36.0%)、HBsAg+HBeAb+HBcAb感染64例(64.0%);宫内感染发生率为25.0%,宫内感染发生率HBsAg+HBeAg+HBcAb孕产妇(22.2%)高于HBsAg+HBeAb+HBcAb孕产妇(3.1%)(P<0.05);HBV-DNA病毒载量阴性6例,10^(3)~10^(5)病毒载量62例、>105病毒载量32例,10^(3)~10^(5)病毒载量孕妇宫内感染发生率(4.8%)低于>10^(5)病毒载量孕妇(21.9%),IL-6水平(8.11±0.89pg/ml)低于>10^(5)病毒载量孕产妇(11.26±1.56pg/ml)且与HBV-DNA载量呈正相关,IFN-γ水平(68.47±7.10pg/L)高于>105病毒载量孕产妇(51.22±5.65pg/L)且与HBV-DNA载量呈负相关(均P<0.05)。结论:感染HBV孕产妇宫内感染发生风险升高,主要感染类型是HBsAg+HBeAb+HBcAb,但HBsAg+HBeAg+HBcAb型、HBV-DNA病毒载量高孕产妇宫内感染风险提高,HBV-DNA病毒载量增加宫内感染风险可能与调控Th1/Th2免疫失衡有关。 展开更多
关键词 孕产妇 乙型肝炎病毒感染 宫内感染 感染类型 病毒载量 炎症因子
下载PDF
宁夏地区孕产妇HBV检测及感染状况调查研究
19
作者 常晶晶 马睿 刘晓东 《宁夏医科大学学报》 2024年第8期836-839,共4页
目的 了解2015—2021年宁夏地区孕产妇乙型肝炎病毒(HBV)检测及感染情况。方法 收集2015—2021年宁夏各助产机构发现并上报的感染HBV的孕产妇信息,通过预防艾滋病、梅毒和乙型肝炎母婴传播信息管理系统收集相关数据,并分析宁夏地区孕产... 目的 了解2015—2021年宁夏地区孕产妇乙型肝炎病毒(HBV)检测及感染情况。方法 收集2015—2021年宁夏各助产机构发现并上报的感染HBV的孕产妇信息,通过预防艾滋病、梅毒和乙型肝炎母婴传播信息管理系统收集相关数据,并分析宁夏地区孕产妇HBV检测率、检测时期和HBV表面抗原(HBsAg)阳性率及其分布特征。结果 2015—2021年宁夏孕产妇HBV检测率99.95%,孕期检测率从69.11%上升至98.13%。累计648 360例孕产妇接受了HBV检测,报告HBsAg阳性孕产妇24 600例,HBsAg阳性率3.79%。24 600例HBsAg阳性孕产妇中,4 847例(19.70%)为仅产时接受检测。孕产妇孕期HBsAg阳性率呈逐年上升趋势,仅产时HBsAg阳性率呈逐年下降趋势,且2015—2019年孕产妇仅产时HBsAg阳性率均高于同期孕产妇孕期HBsAg阳性率。此外,2021年报告2 435例HBV感染孕产妇感染模式,14~<25岁组以模式1感染为主,25~<35岁组、35~<47岁组均以模式2感染为主。结论 2015—2021年宁夏地区孕产妇HBV检测率保持较高水平,孕期检测率显著上升,但仍存在一定比例的产时检测,需进一步采取措施促进孕产妇孕期尽早接受HBV检测,同时加强HBV感染孕产妇疾病监测管理。 展开更多
关键词 孕产妇 乙型肝炎 检测率 阳性率
下载PDF
HBeAg阳性妊娠慢性HBV携带者母婴阻断停药后肝炎活动的危险因素研究
20
作者 刘明 郭艳 +6 位作者 陈文婷 况雪梅 李世炼 揭丽 夏杰 毛青 朱研 《肝脏》 2024年第7期834-839,共6页
目的观察HBeAg阳性妊娠慢性HBV携带者启动以母婴阻断为目的的抗病毒治疗基线至产后96周内HBV RNA、HBV DNA、qHBsAg、qHBeAg、ALT等指标的动态变化,分析产后96周内肝炎活动的危险因素。方法回顾性纳入接受预防性抗病毒治疗并于产后12周... 目的观察HBeAg阳性妊娠慢性HBV携带者启动以母婴阻断为目的的抗病毒治疗基线至产后96周内HBV RNA、HBV DNA、qHBsAg、qHBeAg、ALT等指标的动态变化,分析产后96周内肝炎活动的危险因素。方法回顾性纳入接受预防性抗病毒治疗并于产后12周内停药、且完成产后96周随访的妊娠HBeAg阳性患者,观察抗病毒治疗基线、妊娠36周、产后停药时和/或产后24周、产后96周HBV RNA、HBV DNA、qHBsAg、qHBeAg以及生化学指标的动态变化。结果共纳入146例中位治疗时间为16.4周的HBeAg阳性妊娠慢性HBV携带者。抗病毒治疗期间HBV DNA水平及qHBeAg逐渐下降,HBV RNA逐渐增高,qHBsAg水平在孕36周时较基线降低,停药时升高超过基线水平。产后24周上述指标均反弹接近或超过基线水平。产后96周随访,共5例患者发生HBeAg血清学转换,无一例发生HBsAg清除。产后停药时与产后24周肝炎活动比例最高(30.1%vs.30.8%),但随访至产后96周,仅14例(9.59%)患者因肝炎活动需抗病毒干预。根据是否再次启动抗病毒治疗将患者分为复发组(n=14)与未复发组(n=132)。10例患者在停药6个月以后复发,中位复发时间13.5月。两组间抗病毒治疗药物类型、基线至孕36周HBeAg降幅的差异具有统计学意义。结论HBeAg阳性妊娠慢性HBV携带者预防性抗病毒治疗期间及停药后均有不同比例肝炎活动,停药时、产后24周达高峰,但仅少数患者需再次抗病毒干预,且与HBV活动相关的肝炎发作多发生在停药6个月以后,应加强停药后的长期规律随访。抗病毒基线至孕36周HBeAg降幅是预测产后停药肝炎活动的独立危险因素。 展开更多
关键词 慢性乙型肝炎 慢性乙型肝炎病毒携带孕妇 母婴传播 HbV RNA 肝炎发作
下载PDF
上一页 1 2 31 下一页 到第
使用帮助 返回顶部